E-LIB Suche - Ergebnisse für: de Dios, Alfonso

1

Continuous treatment with abemaciclib leads to sustained an..:

Torres-Guzmán, Raquel ; Ganado, Maria Patricia ; Mur, Cecilia...
Oncotarget. 13 (2022) 1 - p. 864-875 , 2022

Link: https://doi.org/10.18632..

2

Author Correction: Crystal structure of active CDK4-cyclin ..:

Gharbi, Severine Isabelle ; Pelletier, Laura A. ; Espada, Alfonso...
npj Breast Cancer. 8 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

3

Crystal structure of active CDK4-cyclin D and mechanistic b..:

Gharbi, Severine Isabelle ; Pelletier, Laura A. ; Espada, Alfonso...
npj Breast Cancer. 8 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

4

Cyclin dependent kinase (CDK) inhibitors as anticancer drug..:

Sánchez-Martínez, Concepción ; Lallena, María José ; Sanfeliciano, Sonia Gutiérrez.
Bioorganic & Medicinal Chemistry Letters. 29 (2019) 20 - p. 126637 , 2019

Link: https://doi.org/10.1016/..

5

The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed ..:

Schaer, David A. ; Beckmann, Richard P. ; Dempsey, Jack A....
Cell Reports. 22 (2018) 11 - p. 2978-2994 , 2018

Link: https://doi.org/10.1016/..

6

Genomic Aberrations that Activate D-type Cyclins Are Associ..:

Gong, Xueqian ; Litchfield, Lacey M. ; Webster, Yue...
Cancer Cell. 32 (2017) 6 - p. 761-776.e6 , 2017

Link: https://doi.org/10.1016/..

7

Preclinical characterization of abemaciclib in hormone rece..:

Torres-Guzmán, Raquel ; Calsina, Bruna ; Hermoso, Ana...
Oncotarget. 8 (2017) 41 - p. 69493-69507 , 2017

Link: https://doi.org/10.18632..

8

Cyclin dependent kinase (CDK) inhibitors as anticancer drug:

Sánchez-Martínez, Concepción ; Gelbert, Lawrence M. ; Lallena, María José.
Bioorganic & Medicinal Chemistry Letters. 25 (2015) 17 - p. 3420-3435 , 2015

Link: https://doi.org/10.1016/..

9

Preclinical characterization of the CDK4/6 inhibitor LY2835..:

Gelbert, Lawrence M. ; Cai, Shufen ; Lin, Xi...
Investigational New Drugs. 32 (2014) 5 - p. 825-837 , 2014

Link: https://doi.org/10.1007/..

10

Imidazolyl benzimidazoles and imidazo[4,5-b]pyridines as po..:

Mader, Mary ; de Dios, Alfonso ; Shih, Chuan...
Bioorganic & Medicinal Chemistry Letters. 18 (2008) 1 - p. 179-183 , 2008

Link: https://doi.org/10.1016/..

11

p38 mitogen‐activated protein kinase inhibitor LY2228820 en..:

Ishitsuka, Kenji ; Hideshima, Teru ; Neri, Paola...
British Journal of Haematology. 141 (2008) 5 - p. 598-606 , 2008

Link: https://doi.org/10.1111/..

12

Design of Potent and Selective 2-Aminobenzimidazole-Based p..:

de Dios, Alfonso ; Shih, Chuan ; López de Uralde, Beatriz...
Journal of Medicinal Chemistry. 48 (2005) 7 - p. 2270-2273 , 2005

Link: https://doi.org/10.1021/..

13

Dipeptides as Effective Prodrugs of the Unnatural Amino Aci..:

Bueno, Ana Belén ; Collado, Iván ; de Dios, Alfonso...
Journal of Medicinal Chemistry. 48 (2005) 16 - p. 5305-5320 , 2005

Link: https://doi.org/10.1021/..

14

Acyl sulfonamide anti-proliferatives. Part 2: Activity of h..:

Mader, Mary M. ; Shih, Chuan ; Considine, Eileen...
Bioorganic & Medicinal Chemistry Letters. 15 (2005) 3 - p. 617-620 , 2005

Link: https://doi.org/10.1016/..

15

Acyl Sulfonamide Anti-Proliferatives: Benzene Substituent ..:

Lobb, Karen L. ; Hipskind, Philip A. ; Aikins, James A....
Journal of Medicinal Chemistry. 47 (2004) 22 - p. 5367-5380 , 2004

Link: https://doi.org/10.1021/..